Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants

Thorax

Volumn 60, Issue 12, 2005, Pages 1039-1044

  Broughton, S ^b   Roberts, A ^b   Fox, G ^c   Pollina, E ^a   Zuckerman, M ^a   Chaudhry, S ^a   Greenough, A ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB; STEROID;

ARTICLE; ARTIFICIAL VENTILATION; COMPARATIVE STUDY; COUGHING; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GESTATION PERIOD; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; IMMUNOFLUORESCENCE; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHARYNX DISEASE; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RISK FACTOR; SIBLING; SMOKING; TIME SERIES ANALYSIS; VIRUS INFECTION; WHEEZING;

COMMUNITY HEALTH SERVICES; DENMARK; FAMILY PRACTICE; FEMALE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 28244484338     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.037853     Document Type: Article

References (38)

1. Elder DE, Hagan R, Evans SF, et al. Hospital admissions in the first year of life in very preterm infants. J Paediatr Child Health 1999;35:145-50.
2. Petrou S, Mehta Z, Hockley C, et al. The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life. Pediatrics 2003;112:1290-7.
3. Stevenson RC, McCabe CJ, Pharoah PO, et al. Cost of care for a geographically determined population of low birthweight infants to age 8-9 years. I. Children without disability. Arch Dis Child Fetal Neonatal Ed 1996;74:F114-7.
4. Joffe S, Escobar GJ, Black SB, et al. Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics 1999;104:894-9.
5. Lacaze-Masmonteil T, Truffert P, Pinquier D, et al. Lower respiratory tract illness and RSV prophylaxis in very premature infants. Arch Dis Child 2004;89:562-7.
6. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-6.
7. Sampalis JS. Morbidity and mortality after RSV-associated hospitalisations among premature Canadian infants. J Pediatr 2003;141:S150-6.
8. Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child 2001;85:463-8.
9. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-5.
10. Broughton S, Greenough A. Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity. Expert Opin Pharmacother 2003;4:1801-8.
11. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-7.
12. The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997;99:93-9.
13. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 2003;112:1442-6.
14. Thomas MA, Bedford-Russell A, Sharland M. Hospitalisation for RSV infection in ex-preterm infants: implications for use of RSV immune globulin. Arch Dis Child 2000;83:122-7.
15. Clark SJ, Beresford MW, Subhedar NV, et al. Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort. Arch Dis Child 2000;83:313-6.
16. Martinez F, Wright A, Taussig L, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-8.
17. Cifuentes L, Caussade S, Villagran C, et al. Risk factors for recurrent wheezing following acute bronchiolitis: a 12-month follow-up. Pediatr Pulmonol 2003;36:316-21.
18. Liese JG, Grill E, Fischer B, et al. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr 2003;162:230-6.
19. Lanari M, Giovannini M, Giuffre L, et al. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr Pulmonol 2002;33:458-65.
20. Bulkow LR, Singleton RJ, Karron RA, et al. Risk factors for severe respiratory syncytial virus infection among Alaska native children. Pediatrics 2002;109:210-6.
21. Celedon JC, Litonjua AA, Weiss ST, et al. Day care attendance in the first year of life and illnesses of the upper and lower respiratory tract in children with a familial history of atopy. Pediatrics 1999;104:495-500.
22. Schrag S, Zell E, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
23. Fowlie PW, Schmidt B. Diagnostic tests for bacterial infection from birth to 90 days: a systematic review. Arch Dis Child Fetal Neonatal Ed 1998;78:F92-8.
24. Legg JP, Hussain IR, Warner JA, et al. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003;168:633-9.
25. Ray CG, Minnich LL, Holberg CJ, et al. Respiratory syncytial virus-associated lower respiratory illnesses: possible influence of other agents. The Group Health Medical Associates. Pediatr Infect Dis J 1993;12:15-9.
26. Taussig LM, Wright AL, Holberg CJ, et al. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 2003;111:661-75.
27. Young S, O'Keeffe PT, Arnott J, et al. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child 1995;72:16-24.
28. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161:1501-7.
29. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-28.
30. Greenough A, Alexander J, Burgess S, et al. Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection. Arch Dis Child 2004;89:673-8.
31. Milner AD, Marsh MJ, Ingram DM, et al. Effects of smoking in pregnancy on neonatal lung function. Arch Dis Child Fetal Neonatal Ed 1999;80:F8-14.
32. Dezateux C, Stocks J, Dundas I, et al. Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med 1999;159:403-10.
33. Young S, Arnott J, O'Keeffe PT, et al. The association between early life lung function and wheezing during the first 2 yrs of life. Eur Respir J 2000;15:151-7.
34. Turner SW, Young S, Landau LI, et al. Reduced lung function both before bronchiolitis and at 11 years. Arch Dis Child 2002;87:417-20.
35. Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;319:1112-7.
36. Curley AE, Sweet DG, Thornton CM, et al. Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: Implications for antenatal origins or chronic lung disease. Am J Obstet Gynecol 2003;188:871-5.
37. Viscardi RM, Muhumuza CK, Rodriguez A, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004;55:1009-17.
38. Bell MJ, Hallenbeck JM, Gallo V. Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res 2004;56:541-6.